ACE2 and infection: In COVID-19, especially the non-classical RAS is subject of scientific interest, as SARS-CoV-2 uses the ACE2 receptor for cell entry [27] and it has been shown that ACE2 is elevated in severe COVID-19 during a later phase of the infection (Day 9–11) [28].